BrainChip licenses Akida 2 neuromorphic IP to Korea’s EDGEAI in global edge AI push

BrainChip Holdings ( (AU:BRN) ) has shared an update.

BrainChip Holdings has signed a global, non-exclusive technology licensing agreement with Korea-based semiconductor company EDGEAI to integrate BrainChip’s Akida 2 neuromorphic IP into EDGEAI’s upcoming system-on-chip product line for edge and endpoint devices. The deal expands BrainChip’s presence in Asian markets and aligns it with a fast-growing edge AI player focused on ultra-low power, real-time on-device inference across applications including smart cameras, industrial automation and intelligent mobility.

Under the agreement, BrainChip will supply Akida IP, tools and engineering support, with compensation structured around milestone-based payments and ongoing royalties tied to EDGEAI’s sales of Akida-enabled products, expected to become material over time. The partnership strengthens BrainChip’s ecosystem of semiconductor and OEM partners and underscores rising global demand for energy-efficient neuromorphic computing as edge AI deployments accelerate.

The most recent analyst rating on (AU:BRN) stock is a Hold with a A$0.13 price target. To see the full list of analyst forecasts on BrainChip Holdings stock, see the AU:BRN Stock Forecast page.

More about BrainChip Holdings

BrainChip Holdings is a neuromorphic artificial intelligence company that develops Akida, a fully digital, event-based AI processor designed for ultra-low power, on-chip edge processing and learning. Its technology targets real-time, sensor-level intelligence across sectors such as aerospace, autonomous vehicles, industrial IoT, robotics, consumer devices and wearables, reducing reliance on cloud resources.

YTD Price Performance: -17.14%

Average Trading Volume: 8,793,251

Technical Sentiment Signal: Sell

Current Market Cap: A$323.5M

Find detailed analytics on BRN stock on TipRanks’ Stock Analysis page.